Table 1 Clinical characteristics of T2DM patients with or without DPN.
Characteristics | Total (580) | Non-DPN (290) | DPN (290) | P |
|---|---|---|---|---|
Gender (male) | 378 (65.17%) | 189 (65.17%) | 189 (65.17%) | 1.000 |
Age | 53.5 (43–63) | 54 (44–64) | 52 (42–61) | 0.004** |
TSH | 1.70 (1.12–2.58) | 1.65 (1.06–2.50) | 1.75 (1.19–2.67) | 0.108 |
FT3 | 4.87 (4.25–5.51) | 4.99 (4.33–5.56) | 4.77 (4.19–5.42) | 0.084 |
FT4 | 16.2 (14.03–18.3) | 16.4 (14.3–18.83) | 15.95 (13.9–17.8) | 0.017* |
T3 | 1.18 (1.02–1.37) | 1.19 (1.05–1. 4) | 1.17 (1.0–1.35) | 0.087 |
T4 | 7.65 (6.56–8.89) | 7.69 (6.57–8.99) | 7.6 (6.54–8.80) | 0.472 |
TG | 1.51 (1.01–2.23) | 1.49 (1–2.22) | 1.53 (1.02–2.25) | 0.850 |
TC | 4.25 (3.51–4.9) | 4.3 (3.49–4.91) | 4.21 (3.52–4.84) | 0.903 |
LDL | 2.47 (1.91–3.09) | 2.51 (1.89–3.11) | 2.46 (1.93–3.08) | 0.933 |
HDL | 0.99 (0.85–1.21) | 0.99 (0.84–1.22) | 1.0 (0.88–1.2) | 0.565 |
Apo A | 1.19 (1.07–1.33) | 1.20 (1.07–1.35) | 1.18 (1.07–1.32) | 0.400 |
Apo B | 0.83 (.067–1.00) | 0.85 (0.66–1.01) | 0.83 (0.68–0.98) | 0.924 |
Apo E | 36.8 (29.18–48.15) | 37.4 (29.8–49.7) | 36.2 (28.2–46.8) | 0.143 |
Lp (A) | 117 (56.98–228) | 123 (60–228) | 105.7 (55–232) | 0.506 |
AST | 19 (15–25) | 20 (16–26) | 18 (15–23) | 0.001** |
LDH | 182 (161–204) | 182.5 (162–206) | 179 (159–200) | 0.170 |
CK | 73 (53–100) | 74.5 (55–103.5) | 70 (50–94) | 0.105 |
CK-MB | 13 (10–16) | 12 (10–16) | 13 (10.65–16) | 0.429 |
α-HBDH | 146 (131–166) | 148 (132.75–168) | 142 (124.5–160.5) | 0.015* |
SOD | 170.4 (154.1–188.4) | 177.5 (161.38–194.63) | 161.7 (146.4–177.9) | 0.000*** |
AG | 23.8 (21.2–26.6) | 23.8 (21.5–26.6) | 23.74 (20.91–26.65) | 0.533 |
Ca | 2.22 (2.15–2.29) | 2.24 (2.16–2.31) | 2.21 (2.14–2.27) | 0.001** |
K | 3. 9 (3.69–4.18) | 3.93 (3.73–4.19) | 3.89 (3.65–4.15) | 0.237 |
P | 1.15 (1.02–1.28) | 1.16 (1.03–1.28) | 1.14 (1.01–1.26) | 0.287 |
CL | 103.4 (101–105.7) | 103.45 (101.1–105.6) | 103.3 (100.85–105.8) | 0.842 |
Mg | 0.9 (0.85–0.96) | 0.9 (0.86–0.96) | 0.9 (0.85–0.96) | 0.985 |
Na | 142 (140.3–144) | 142 (141–144) | 142 (140–144) | 0.093 |
CO2CP | 22 (19.9–24.3) | 22 (19.8–24.3) | 21.9 (19.95–24.2) | 0.863 |
Cr | 57 (47–67) | 58 (48.75–67.25) | 56 (46–66) | 0.041* |
BUN | 5.26 (4.42–6.25) | 5.25 (4.43–6.27) | 5.29 (4.4–6.22) | 0.803 |
UA | 315 (257.45–374.78) | 325.5 (267–386) | 298.45 (249.28–366) | 0.005** |
GLU | 6.93 (5.68–9.07) | 6.8 (5.66–8.63) | 7.18 (5.76–9.48) | 0.113 |
RBP | 52.4 (39.3–66.3) | 54.35 (40.33–66.93) | 47.2 (37.85–62.85) | 0.049* |
GA | 19.2 (16.01–23.2) | 18.95 (15.8–22.93) | 19.75 (16.4–23.45) | 0.135 |
CysC | 0.82 (0.72–0.93) | 0.82 (0.72–0.93) | 0.82 (0.72–0.94) | 0.789 |
PA | 254.95 (215.6–291.95) | 257.2 (221.13–292.88) | 247.9 (205.43–291.53) | 0.186 |
TP | 66.8 (63.23–71.4) | 67.5 (63.5–72.03) | 66.2 (62.98–70.73) | 0.015* |
ALB | 41.4 (39–44.2) | 42.3 (39.1–45.03) | 41 (38.6–43.23) | 0.001** |
ALP | 71 (57–89) | 70 (55.75–87) | 72 (60–89.75) | 0.107 |
GLB | 25.3 (23.1–28) | 25.45 (23.3–28.2) | 25.15 (22.9–27.93) | 0.290 |
ALT | 20 (14.5–32) | 22 (15–38) | 19.7 (14.23–29.28) | 0.020* |
